Megan S. Lim

20.8k total citations · 1 hit paper
230 papers, 8.2k citations indexed

About

Megan S. Lim is a scholar working on Pathology and Forensic Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Megan S. Lim has authored 230 papers receiving a total of 8.2k indexed citations (citations by other indexed papers that have themselves been cited), including 131 papers in Pathology and Forensic Medicine, 84 papers in Oncology and 83 papers in Molecular Biology. Recurrent topics in Megan S. Lim's work include Lymphoma Diagnosis and Treatment (126 papers), Viral-associated cancers and disorders (40 papers) and Chronic Lymphocytic Leukemia Research (34 papers). Megan S. Lim is often cited by papers focused on Lymphoma Diagnosis and Treatment (126 papers), Viral-associated cancers and disorders (40 papers) and Chronic Lymphocytic Leukemia Research (34 papers). Megan S. Lim collaborates with scholars based in United States, Canada and South Korea. Megan S. Lim's co-authors include Kojo S.J. Elenitoba‐Johnson, Delphine Rolland, Elaine S. Jaffe, Bryan L. Betz, Zhaosheng Lin, David K. Crockett, Noah A. Brown, Nathanael G. Bailey, Richard C. Jordan and Helmut C. Weigelin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Advanced Materials and Journal of Biological Chemistry.

In The Last Decade

Megan S. Lim

218 papers receiving 8.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study

2013 477 citations Megan S. Lim, Delphine Rolland et al. profile →

Peers

Megan S. Lim

ONCOL

PFM

IMMUN

GENET

Felipe Samaniego United States

Ken H. Young United States

George W. Wright United States

Suresh C. Jhanwar United States

Hans Tesch Germany

Liqiang Xi United States

Kirsten Grønbæk Denmark

Lia Gore United States

Carmelo Carlo‐Stella Italy

Kiyohiko Hatake Japan

Felipe Samaniego United States

Megan S. Lim

2.1k ×0.7

3.2k ×1.1

ONCOL

3.1k ×1.1

PFM

1.2k ×0.8

IMMUN

1.5k ×1.4

GENET

Citations per year, relative to Megan S. Lim Megan S. Lim (= 1×) peers Felipe Samaniego

Countries citing papers authored by Megan S. Lim

Since Specialization

Citations

This map shows the geographic impact of Megan S. Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Megan S. Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Megan S. Lim more than expected).

Fields of papers citing papers by Megan S. Lim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Megan S. Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Megan S. Lim. The network helps show where Megan S. Lim may publish in the future.

Co-authorship network of co-authors of Megan S. Lim

This figure shows the co-authorship network connecting the top 25 collaborators of Megan S. Lim. A scholar is included among the top collaborators of Megan S. Lim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Megan S. Lim. Megan S. Lim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bagg, Adam, Mary Jo Lechowicz, Daisy Alapat, et al.. (2024). The Development of Diagnostic Criteria and Utilization of Excisional Lymph Node Biopsies Shorten Time to Diagnosis for Idiopathic Multicentric Castleman Disease. Blood. 144(Supplement 1). 1156–1156. 1 indexed citations

Campo, Elı́as, Daan Dierickx, Stefan Dirnhofer, et al.. (2024). Lymphoma Classifications, How to Develop a Future Unified Taxonomy. Journal of Clinical Oncology. 42(27). 3177–3182. 7 indexed citations

Shaw, Timothy I., Stanley Pounds, Xueyuan Cao, et al.. (2024). Comprehensive genomic analysis reveals molecular heterogeneity in pediatric ALK-positive anaplastic large cell lymphoma. Leukemia. 39(1). 199–210. 1 indexed citations

Lim, Megan S., et al.. (2023). Biopathology of childhood, adolescent and young adult non-Hodgkin lymphoma. Best Practice & Research Clinical Haematology. 36(1). 101447–101447.

Pierson, Sheila K., Megan S. Lim, Gordan Srkalović, et al.. (2023). Treatment consistent with idiopathic multicentric Castleman disease guidelines is associated with improved outcomes. Blood Advances. 7(21). 6652–6664. 16 indexed citations

Fajgenbaum, David C., Sheila K. Pierson, Karan Kanhai, et al.. (2022). The disease course of Castleman disease patients with fatal outcomes in the ACCELERATE registry. British Journal of Haematology. 198(2). 307–316. 4 indexed citations

Wu, Rui, Guang Yang, Robyn T. Sussman, et al.. (2022). Rapid and Automated Semiconductor-Based Next-Generation Sequencing for Simultaneous Detection of Somatic DNA and RNA Aberrations in Myeloid Neoplasms. Journal of Molecular Diagnostics. 25(2). 87–93. 7 indexed citations

Belyaeva, Elizaveta, et al.. (2022). Bone marrow findings of idiopathic Multicentric Castleman disease: A histopathologic analysis and systematic literature review. Hematological Oncology. 40(2). 191–201. 13 indexed citations

Pierson, Sheila K., Adam Bagg, Daisy Alapat, et al.. (2021). Characterization of Castleman Disease Reveals Patients with Oligocentric Adenopathy and Clinicopathologic Characteristics Similar to Unicentric Castleman Disease. Blood. 138(Supplement 1). 1622–1622. 2 indexed citations

10.

Wing, Anna, Jason Xu, Wenzhao Meng, et al.. (2021). Transcriptome and unique cytokine microenvironment of Castleman disease. Modern Pathology. 35(4). 451–461. 22 indexed citations

11.

Lowe, Eric, Anne F. Reilly, Megan S. Lim, et al.. (2021). Brentuximab vedotin in combination with chemotherapy for pediatric patients with ALK+ ALCL: results of COG trial ANHL12P1. Blood. 137(26). 3595–3603. 46 indexed citations

12.

Amin, Amit Dipak, Lingxiao Li, Delphine Rolland, et al.. (2019). The mechanism of cancer drug addiction in ALK-positive T-Cell lymphoma. Oncogene. 39(10). 2103–2117. 6 indexed citations

13.

Shereck, Evan, Nancy S. Day, Aradhana Awasthi, et al.. (2019). Immunophenotypic, cytotoxic, proteomic and genomic characterization of human cord blood vs. peripheral blood CD56^Dim NK cells. Innate Immunity. 25(5). 294–304. 8 indexed citations

14.

Murga‐Zamalloa, Carlos, Delphine Rolland, Avery Polk, et al.. (2019). Colony-Stimulating Factor 1 Receptor (CSF1R) Activates AKT/mTOR Signaling and Promotes T-Cell Lymphoma Viability. Clinical Cancer Research. 26(3). 690–703. 48 indexed citations

15.

Polk, Avery, Ye Lu, Tianjiao Wang, et al.. (2016). Colony-Stimulating Factor-1 Receptor Is Required for Nurse-like Cell Survival in Chronic Lymphocytic Leukemia. Clinical Cancer Research. 22(24). 6118–6128. 38 indexed citations

16.

Wang, Tianjiao, Ye Lu, Avery Polk, et al.. (2016). T-cell Receptor Signaling Activates an ITK/NF-κB/GATA-3 axis in T-cell Lymphomas Facilitating Resistance to Chemotherapy. Clinical Cancer Research. 23(10). 2506–2515. 45 indexed citations

17.

Udager, Aaron M., Delphine Rolland, Jonathan B. McHugh, et al.. (2015). High-Frequency Targetable EGFR Mutations in Sinonasal Squamous Cell Carcinomas Arising from Inverted Sinonasal Papilloma. Cancer Research. 75(13). 2600–2606. 97 indexed citations

18.

Kiel, Mark J., Anagh A. Sahasrabuddhe, Delphine Rolland, et al.. (2015). Genomic analyses reveal recurrent mutations in epigenetic modifiers and the JAK–STAT pathway in Sézary syndrome. Nature Communications. 6(1). 8470–8470. 143 indexed citations

19.

Brown, Noah A., Delphine Rolland, Jonathan B. McHugh, et al.. (2014). Activating FGFR2–RAS–BRAF Mutations in Ameloblastoma. Clinical Cancer Research. 20(21). 5517–5526. 206 indexed citations

20.

El‐Mallawany, Nader Kim, J. Kimble Frazer, Pieter Van Vlierberghe, et al.. (2012). Pediatric T- and NK-cell lymphomas: new biologic insights and treatment strategies. Blood Cancer Journal. 2(4). e65–e65. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact